NMRA Competitors & Alternatives
Compare Neumora Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
NMRA
Main Stock$1.63
Tradestie Score
53
Market Cap
$288.26M
Analyst Upside
+446.5%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAPR
Capricor Therapeutics Inc
|
$26.71
|
$357.51M | - | 53 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$13.51
|
$354.45M | - | 51 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$28.53
|
$353.70M | - | 55 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.80
|
$350.98M | - | 56 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.71
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.29
|
$332.96M | - | 58 | Compare |
|
REPL
Replimune Group, Inc.
|
$9.47
|
$328.62M | - | 57 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.51
|
$304.12M | - | 60 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$16.94
|
$297.23M | - | 51 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$29.00
|
$293.03M | - | 49 | Compare |
More NMRA Analysis
Data updated: Jun 06, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry